newsfilter
← Latest News
Business Wire·

Cortexyme Appoints Marwan Sabbagh, MD, to its Board of Directors

Cortexyme, Inc. (NASDAQ:CRTX), a clinical-stage biopharmaceutical company pioneering upstream therapeutic approaches to improve the lives of patients diagnosed with degenerative diseases, today announced the appointment of Marwan Noel Sabbagh, MD, FAAN,